Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruiz Borrego

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Age-period-cohort analysis of breast cancer mortality rates in Andalucia (Spain)A Cayuela, S Rodríguez-Domínguez, M Ruiz-Borrego, et al.
Revista Clinica Espanola|October 6, 2009
[Treatment of aggressive non-Hodgkin's lymphomas]J A Moreno Nogueira, M Ruiz Borrego, B Pérez Valderrama, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Cost-effectiveness analysis of docetaxel (Taxotere) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancerM Martín-Jiménez, A Rodríguez-Lescure, M Ruiz-Borrego, et al.
Cancer Treatment and Research Communications|February 5, 2021
Safety and efficacy of trastuzumab emtansine (TDM-1) in a patient on hemodialysis for renal failureA Falcón González, P Estévez Garcia, A Sánchez Gastaldo, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|March 1, 1997
[Acute liver failure as presentation form of small cell carcinoma of the lung]M J Valladares Ayerbes, M Cañadas Garcia de León, J J Reina Zoilo, et al.
Scientific Reports|February 20, 2021
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancerI Blancas, C Olier, V Conde, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|May 16, 1998
[Primary endobronchial non-hodgkins lymphoma: description of a case and review of the literature]J J Reina Zoilo, M Ruiz Borrego, J C Valenzuela Claros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4)M Martín, A Chan, L Dirix, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Age-period-cohort analysis of breast cancer mortality rates in Andalucia (Spain)A Cayuela, S Rodríguez-Domínguez, M Ruiz-Borrego, et al.
Revista Clinica Espanola|October 6, 2009
[Treatment of aggressive non-Hodgkin's lymphomas]J A Moreno Nogueira, M Ruiz Borrego, B Pérez Valderrama, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Cost-effectiveness analysis of docetaxel (Taxotere) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancerM Martín-Jiménez, A Rodríguez-Lescure, M Ruiz-Borrego, et al.
Cancer Treatment and Research Communications|February 5, 2021
Safety and efficacy of trastuzumab emtansine (TDM-1) in a patient on hemodialysis for renal failureA Falcón González, P Estévez Garcia, A Sánchez Gastaldo, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|March 1, 1997
[Acute liver failure as presentation form of small cell carcinoma of the lung]M J Valladares Ayerbes, M Cañadas Garcia de León, J J Reina Zoilo, et al.
Scientific Reports|February 20, 2021
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancerI Blancas, C Olier, V Conde, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|May 16, 1998
[Primary endobronchial non-hodgkins lymphoma: description of a case and review of the literature]J J Reina Zoilo, M Ruiz Borrego, J C Valenzuela Claros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4)M Martín, A Chan, L Dirix, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.
Pageof 3